Clinical Trial Update: Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vinorelbine with or without trastuzumab in women with progressive metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED